{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:56:04Z","timestamp":1760079364789},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T00:00:00Z","timestamp":1215993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T00:00:00Z","timestamp":1215993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/bmt.2008.201","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T11:03:34Z","timestamp":1216033414000},"page":"529-534","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma"],"prefix":"10.1038","volume":"42","author":[{"given":"S","family":"Murali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Winton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E K","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L T","family":"Heffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lonial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Lechowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K P","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H J","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Langston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,14]]},"reference":[{"key":"BFbmt2008201_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16: 637\u2013640.","journal-title":"Am J Surg Pathol"},{"key":"BFbmt2008201_CR2","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","volume":"23","author":"G Lenz","year":"2005","unstructured":"Lenz G, Dreyling M, Hoster E, Wormann B, Duhrsen U, Metzner B et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 2005; 23: 1984\u20131992.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bmt.1703925","volume":"31","author":"G Hess","year":"2003","unstructured":"Hess G, Flohr T, Huber C, Kolbe K, Derigs HG, Fischer T . Safety and feasibility of CHOP\/rituximab induction treatment followed by high-dose chemo\/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin\u2032s lymphoma. Bone Marrow Transplant 2003; 31: 775\u2013782.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008201_CR4","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1200\/JCO.2002.20.5.1288","volume":"20","author":"OM Howard","year":"2002","unstructured":"Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ et al. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol 2002; 20: 1288\u20131294.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR5","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H, Palmer JL, Pugh WC, Korbling M et al. Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 1998; 16: 3803\u20133809.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00277-006-0193-2","volume":"86","author":"DS Ritchie","year":"2007","unstructured":"Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S et al. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma. Ann Hematol 2007; 86: 101\u2013105.","journal-title":"Ann Hematol"},{"key":"BFbmt2008201_CR7","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1200\/JCO.2005.01.1825","volume":"23","author":"JE Romaguera","year":"2005","unstructured":"Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B et al. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol 2005; 23: 7013\u20137023.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR8","doi-asserted-by":"crossref","unstructured":"Epner E, Unger J, Miller T, Rimzsa L, Spier C, Leblanc M . A multi center trial of hyperCVAD+Rituxan in patients with newly diagnosed mantle cell lymphoma. Blood 2007; 110 (abstract 38).","DOI":"10.1182\/blood.V110.11.387.387"},{"key":"BFbmt2008201_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1034\/j.1600-0609.2003.00093.x","volume":"71","author":"NS Andersen","year":"2003","unstructured":"Andersen NS, Pedersen L, Elonen E, Johnson A, Kolstad A, Franssila K et al. Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. Eur J Haematol 2003; 71: 73\u201380.","journal-title":"Eur J Haematol"},{"key":"BFbmt2008201_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","volume":"25","author":"D Decaudin","year":"2000","unstructured":"Decaudin D, Brousse N, Brice P, Haioun C, Bourhis JH, Morel P et al. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study. Bone Marrow Transplant 2000; 25: 251\u2013256.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008201_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1365-2141.2003.04140.x","volume":"120","author":"E Vandenberghe","year":"2003","unstructured":"Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, Lopez-Guillermo A, Gisselbrecht C et al. Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol 2003; 120: 793\u2013800.","journal-title":"Br J Haematol"},{"key":"BFbmt2008201_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.thj.6200007","volume":"1","author":"P Dreger","year":"2000","unstructured":"Dreger P, Martin S, Kuse R, Sonnen R, Glass B, Kroger N et al. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients. Hematol J 2000; 1: 87\u201394.","journal-title":"Hematol J"},{"key":"BFbmt2008201_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbmt.2004.09.007","volume":"11","author":"YL Kasamon","year":"2005","unstructured":"Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E et al. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant 2005; 11: 39\u201346.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008201_CR14","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1200\/JCO.2003.05.501","volume":"21","author":"IF Khouri","year":"2003","unstructured":"Khouri IF, Lee MS, Saliba RM, Jun G, Fayad L, Younes A et al. Nonablative allogeneic stem cell transplantation for advanced\/recurrent mantle-cell lymphoma. J Clin Oncol 2003; 21: 4407\u20134412.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/annonc\/mdh069","volume":"15","author":"J Mangel","year":"2004","unstructured":"Mangel J, Leitch HA, Connors JM, Buckstein R, Imrie K, Spaner D et al. Intensive chemotherapy and autologous stem cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis. Ann Oncol 2004; 15: 283\u2013290.","journal-title":"Ann Oncol"},{"key":"BFbmt2008201_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","volume":"22","author":"N Milpied","year":"1998","unstructured":"Milpied N, Gaillard F, Moreau P, Mahe B, Souchet J, Rapp MJ et al. High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience. Bone Marrow Transplant 1998; 22: 645\u2013650.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008201_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579\u2013586.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008201_CR19","volume-title":"Marrow Transplantation: Practical and Technical Aspects of Stem Cell Reconstitution","author":"R Sacher","year":"1992","unstructured":"Sacher R, Aubuchon J . Marrow Transplantation: Practical and Technical Aspects of Stem Cell Reconstitution. Amer Assn of Blood Banks, Bethesda, MD, 1992."},{"key":"BFbmt2008201_CR20","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/cncr.11838","volume":"98","author":"IF Khouri","year":"2003","unstructured":"Khouri IF, Saliba RM, Okoroji GJ, Acholonu SA, Champlin RE . Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score. Cancer 2003; 98: 2630\u20132635.","journal-title":"Cancer"},{"key":"BFbmt2008201_CR21","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"M Dreyling","year":"2005","unstructured":"Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677\u20132684.","journal-title":"Blood"},{"key":"BFbmt2008201_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/jnci\/djk152","volume":"99","author":"H Schulz","year":"2007","unstructured":"Schulz H, Bohlius JF, Trelle S, Skoetz N, Reiser M, Kober T et al. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst 2007; 99: 706\u2013714.","journal-title":"J Natl Cancer Inst"},{"key":"BFbmt2008201_CR23","doi-asserted-by":"crossref","unstructured":"Vose J, Loberiza F, Bierman B, Bociek G, Armitage J . Mantle cell lymphoma (MCL): Induction therapy with HyperCVAD\/High-dose methotrexate and cytarabine (M-C) (\u00b1rituximab) improves results of autologous stem cell transplant in first remission. Journal of Clinical Oncology 2006 ASCO Annual Meeting Proceedings Part I Vol 24, No 18S (June 20 Supplement), 2006: 7511. 2007.","DOI":"10.1200\/jco.2006.24.18_suppl.7511"},{"key":"BFbmt2008201_CR24","first-page":"1580","volume":"90","author":"S Vigouroux","year":"2005","unstructured":"Vigouroux S, Gaillard F, Moreau P, Harousseau JL, Milpied N . High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma. Haematologica 2005; 90: 1580\u20131582.","journal-title":"Haematologica"},{"key":"BFbmt2008201_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ajh.20646","volume":"81","author":"N Laudi","year":"2006","unstructured":"Laudi N, Arora M, Burns L, McGlave P, Miller J, Bohac G et al. Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma. Am J Hematol 2006; 81: 519\u2013524.","journal-title":"Am J Hematol"},{"key":"BFbmt2008201_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1702567","volume":"26","author":"C Martinez","year":"2000","unstructured":"Martinez C, Carreras E, Rovira M, Urbano-Ispizua A, Esteve J, Perales M et al. Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation. Bone Marrow Transplant 2000; 26: 677\u2013679.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008201_CR27","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1158\/1078-0432.CCR-04-2425","volume":"11","author":"M Hoogendoorn","year":"2005","unstructured":"Hoogendoorn M, Olde Wolbers J, Smit WM, Schaafsma MR, Jedema I, Barge RM et al. Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation. Clin Cancer Res 2005; 11: 5310\u20135318.","journal-title":"Clin Cancer Res"},{"key":"BFbmt2008201_CR28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1023\/A:1008380527502","volume":"10","author":"IF Khouri","year":"1999","unstructured":"Khouri IF, Lee MS, Romaguera J, Mirza N, Kantarjian H, Korbling M et al. Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. Ann Oncol 1999; 10: 1293\u20131299.","journal-title":"Ann Oncol"},{"key":"BFbmt2008201_CR29","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","volume":"104","author":"MB Maris","year":"2004","unstructured":"Maris MB, Sandmaier BM, Storer BE, Chauncey T, Stuart MJ, Maziarz RT et al. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 2004; 104: 3535\u20133542.","journal-title":"Blood"},{"key":"BFbmt2008201_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1705074","volume":"36","author":"NH Russell","year":"2005","unstructured":"Russell NH, Byrne JL, Faulkner RD, Gilyead M, Das-Gupta EP, Haynes AP . Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 437\u2013441.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008201_CR31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/blood.V110.11.389.389","volume":"110","author":"M Smith","year":"2007","unstructured":"Smith M, Zhang L, Gordon L, Foran J, Kahl B, Gascoyne R et al. Phase II Study of R-CHOP Followed by 90Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499. Blood 2007; 110: 389.","journal-title":"Blood"},{"key":"BFbmt2008201_CR32","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/cncr.21313","volume":"104","author":"C Thieblemont","year":"2005","unstructured":"Thieblemont C, Antal D, Lacotte-Thierry L, Delwail V, Espinouse D, Michallet AS et al. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma. Cancer 2005; 104: 1434\u20131441.","journal-title":"Cancer"},{"key":"BFbmt2008201_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2002-08-2476","volume":"102","author":"AM Gianni","year":"2003","unstructured":"Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S et al. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 2003; 102: 749\u2013755.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:47:03Z","timestamp":1648036023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,14]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["BFbmt2008201"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.201","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,14]]},"assertion":[{"value":"28 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}